VBI Vaccines, Inc. (VBIV) Financial Statements (2024 and earlier)

Company Profile

Business Address 160 SECOND STREET
CAMBRIDGE, MA 02142
State of Incorp. BC
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments62,629121,694119,10144,21359,27067,694
Cash and cash equivalents62,629121,69493,82544,21359,27067,694
Short-term investments   25,276   
Receivables9487720156143
Inventory, net of allowances, customer advances and progress billings6,5992,5762,1521,075911788
Inventory6,5992,5762,1521,075911788
Prepaid expense2,3092,3731,5691,024982951
Other current assets6,0593,6339,142450512850
Total current assets:77,690130,284132,04146,96361,73170,426
Noncurrent Assets
Operating lease, right-of-use asset3,3163,3441,5541,459
Property, plant and equipment12,25311,03710,72110,1958,5252,245
Intangible assets, net (including goodwill)60,47264,35264,41762,96466,51472,310
Goodwill2,1272,2612,2612,2088,2658,974
Intangible assets, net (excluding goodwill)58,34562,09162,15660,75658,24963,336
Other noncurrent assets1,3551,259639620835675
Total noncurrent assets:77,39679,99277,33175,23875,87475,230
TOTAL ASSETS:155,086210,276209,372122,201137,605145,656
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities12,9734,2803,7341,1276,0551,810
Accounts payable12,9734,2803,7341,1276,0551,810
Deferred revenue409526255882
Debt   642  
Due to related parties   14,8451,1001,600
Contract with customer, liability2,375
Other liabilities22,58826,94112,41512,26113,8479,826
Other undisclosed current liabilities972839944   
Total current liabilities:36,94232,58617,34829,75723,37713,236
Noncurrent Liabilities
Long-term debt and lease obligation 48,88830,95716,948817  
Long-term debt, excluding current maturities 48,88828,44116,329   
Liabilities, other than long-term debt4,5692,2772,8492,90915,72412,207
Deferred revenue and credits669
Deferred revenue2,2042,2772,8492,909
Contract with customer, liability2,797
Due to related parties    12,92711,538
Operating lease, liability2,3652,516619817
Other undisclosed noncurrent liabilities524574522463371426
Total noncurrent liabilities:53,98133,80820,3194,18916,09512,633
Total liabilities:90,92366,39437,66733,94639,47225,869
Equity
Equity, attributable to parent64,163143,882171,70588,25598,133119,787
Common stock442,312442,235403,528284,965246,417201,806
Additional paid in capital90,02081,58375,53066,43063,44960,891
Accumulated other comprehensive income (loss)21,440(1,565)1,265(752)(4,158)1,065
Accumulated deficit(489,609)(378,371)(308,618)(262,388)(207,575)(143,975)
Total equity:64,163143,882171,70588,25598,133119,787
TOTAL LIABILITIES AND EQUITY:155,086210,276209,372122,201137,605145,656

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues1,0826311,0612,2213,355865
Cost of revenue   (9,168)(7,904)(4,509)(5,193)
Gross profit:1,082631(8,107)(5,683)(1,154)(4,328)
Operating expenses(82,902)(68,663)(44,678)(54,620)(63,763)(38,145)
Other undisclosed operating income   9,1687,9044,5095,193
Operating loss:(81,820)(68,032)(43,617)(52,399)(60,408)(37,280)
Nonoperating income (expense)
(Gain (Loss), Foreign Currency Transaction, before Tax)
(27,476)3,01195(218)(560)736
Interest and debt expense(4,007)(4,732)(2,708)(2,196)(2,632)2,882
Loss from continuing operations before equity method investments, income taxes:(113,303)(69,753)(46,230)(54,813)(63,600)(33,662)
Other undisclosed loss from continuing operations before income taxes      (5,764)
Loss from continuing operations before income taxes:(113,303)(69,753)(46,230)(54,813)(63,600)(39,426)
Income tax benefit      431
Loss from continuing operations:(113,303)(69,753)(46,230)(54,813)(63,600)(38,995)
Loss before gain (loss) on sale of properties:(69,753)(46,230)(54,813)(63,600)(38,995)
Net loss attributable to parent:(113,303)(69,753)(46,230)(54,813)(63,600)(38,995)
Other undisclosed net loss available to common stockholders, basic      
Net loss available to common stockholders, diluted:(113,303)(69,753)(46,230)(54,813)(63,600)(38,995)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(113,303)(69,753)(46,230)(54,813)(63,600)(38,995)
Other comprehensive income (loss)23,005(2,830)2,017 (5,223)4,261
Comprehensive loss:(90,298)(72,583)(44,213)(54,813)(68,823)(34,734)
Other undisclosed comprehensive income, net of tax, attributable to parent    3,406  
Comprehensive loss, net of tax, attributable to parent:(90,298)(72,583)(44,213)(51,407)(68,823)(34,734)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: